NCT03607097

Integral Management of Healthcare Problems Related With Drugs in Polimedicated Patients: Medication Code

Status unknown NA Last updated 13 February 2020

What this trial tests

NA trial testing Secondary prevention program for drug related problems in Drug Related Problems in 808 participants. Status unknown.

Timeline

28 August 2018

Primary endpoint
30 October 2020

31 December 2020

Quick facts

Lead sponsor	Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	health services research
Enrollment	808
Start date	28 August 2018
Primary completion	30 October 2020
Estimated completion	31 December 2020
Sites	1 location across Spain

Drugs / interventions tested

• Secondary prevention program for drug related problems

Conditions studied

• Drug Related Problems — all drugs for Drug Related Problems →
• Pharmaceutical Care — all drugs for Pharmaceutical Care →

Sponsor

Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau

Who can join

18 and older, any sex, with Drug Related Problems or Pharmaceutical Care. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Background:

Although Drug- related Problems (DRPs) in polimedicated patients are a major public health problem in western countries and many of them have been considered avoidable, secondary and primary prevention policies have not been systematized, beyond pharmaceutical care programs in certain settings and on specific patients.

Objectives:

The main objective of this study is to evaluate the impact of implementing the Medication Code (CM) on patients who consult the emergency department for a DRP (secondary prevention of DRP). It is also intended to draw conclusions, based on the knowledge obtained in terms of DRP that will allow the establishment of future actions to reduce its prevalence (primary prevention actions).

Method:

A single-centre clinical trial is proposed in which adult patients will be selected to consult the Hospital Emergency Department (ED) of the Hospital de la Santa Creu i Sant Pau (HSCSP) for a primary or secondary diagnosis of DRP and will be randomised with a 1:1 distribution to be included in the medication code (intervention group) or to receive usual care (control group). The intervention will be evaluated in terms of health outcomes (ED consultations and hospital readmission).

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

1. The Effect of the Drug-Related Problems Prevention Bundle on Early Readmissions in Patients From the Emergency Department: A Randomized Clinical Trial.
   Juanes A, Ruíz J, Puig M, Blázquez M, et al · · 2023 · cited 8× · PMID 36539949 · DOI 10.1177/10600280221143237
2. Cost-Effectiveness Analysis of Implementing a Secondary Prevention Programme in Those Patients Who Visited an Emergency Department for Drug-Related Problems
   Ruiz J, Juanes-Borrego A, Puig-Campmany M, Blazquez-Andion M, et al · · 2021 · DOI 10.21203/rs.3.rs-659198/v1